Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05027789 · ClinicalTrials.gov registry record · NA
Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention
A NA study of Cognitive Impairment and Memory Disorders, sponsored by University of California, Davis.
- Active
- Registry status
- NA
- Development phase
- 263
- Enrollment target
- 1
- Study location
NCT05027789: Active NA study of Cognitive Impairment and Memory Disorders, sponsored by University of California, Davis.
NCT05027789 is a NA study of Cognitive Impairment and Memory Disorders that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 263 participants, below the 663-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05027789, a NA study of Cognitive Impairment and Memory Disorders, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 263 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine if training in memory support aids and healthy lifestyle activities (physical exercise, mentally stimulating activities and stress management) can have a positive effect on memory, thinking, and activities that people do every day. Participation in this study will involve being placed into one of two groups: a Self-Guided Intervention Group or a Structured Intervention Group. Both groups will be asked to attend group sessions in which they will be provided education on memory support strategies and lifestyle changes. The Structured Intervention Group will also be provided with an iPad and a digital application (called EMMA) to track their activity. Study participation involves a 6-month intervention and completing outcome measures at 4 different time points for up to a year.
Primary Outcome
A standardized assessment of narrative episodic memory.
Conditions Studied
Interventions
- BEHAVIORAL Self-Guided
- BEHAVIORAL Structured Group
Study Locations (1)
California
- University of California, Davis Alzheimer's Disease Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2021-08-13 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT05027789 still lists
NCT05027789 is an interventional study that assigns participants to a tested intervention. The registered 263 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (60% lower).
The record links to 2 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Self-Guided is the first listed.
NCT05027789 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05027789 about?
NCT05027789 is a clinical study titled "Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention". The purpose of this research is to determine if training in memory support aids and healthy lifestyle activities (physical exercise, mentally stimulating activities and stress management) can have a positive effect on memory, thinking, and activities that people do every day. Participation in this s...
What is the current status of trial NCT05027789?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 263 participants. The study started on 2021-08-13. Estimated completion is 2026-08-31.
What conditions does trial NCT05027789 study?
This clinical trial studies the following conditions: Cognitive Impairment, Memory Disorders.
What interventions are being tested in trial NCT05027789?
The interventions under investigation include: Self-Guided (BEHAVIORAL), Structured Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05027789?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05027789 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05027789's enrollment target sits among peer trials
263 19th of 105 higher than 87 of 105 other Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04067336 · 263 participants · Phase 1
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- NCT06234423 · 263 participants · Phase 1
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- NCT06724627 · 263 participants · NA
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI